期刊文献+

不同阶段2型糖尿病患者血清脑钠肽水平 被引量:5

Research on Correlation Between Brain Natriuretic Peptide and Type 2 Diabetic Nephropathy
下载PDF
导出
摘要 目的:探讨不同阶段2型糖尿病患者血清中脑钠肽(BNP)水平的改变。方法:2型糖尿病患者75例,按尿微量白蛋白(Alb)/肌酐(Cr)值分为正常蛋白尿组(Alb/Cr<30 mg/g),微量蛋白尿组(30 mg/g≤Alb/Cr<300 mg/g),大量蛋白尿组(Alb/Cr≥300 mg/g),采用罗氏电化学发光法检测3组患者血清BNP水平,分析不同阶段2型糖尿病BNP水平的变化,检测Cr、胱抑素-c(Cys-c)、尿素氮(UREA)等血生化指标。结果:微量蛋白尿组和大量蛋白尿组BNP水平均明显高于正常蛋白尿组,大量蛋白尿组高于微量蛋白尿组,差异有统计学意义(P<0.05);Cr、Cys-c、UREA在对照组、微量蛋白尿组和大量蛋白尿组和呈升高趋势,差异有统计学意义(P<0.05)。结论:随着2型糖尿病患者肾功能的下降BNP水平升高。 Objective: To investigate correlations of BNP levels with renal functions, glucose, lipids and other factors by measuring BNP levels of Type 2 diabetic patients. Methods: Seventy-five diabetics who received treatment from February 2013 to July 2014 in our department and conformed to inclusion standards. 75 diabetics in the diabetes group were further divided into three small groups: the normal- buminuric group ( UmAlb/C 〈 30 mg/g) with 25 cases, the microalbuminuric group (30 mg/g ≤ Um- Alb/C 〈300 mg/g) with 31 cases, and the macroalbuminuric group( UmAlb/C≥300 mg/g) with 19 cases. Results: The BNP levels of patients in the microalbuminuric group and macroalbuminuric group were significantly higher than the BNP level of patients in the normalbuminuric group, while and the BNP level of patients in the macroalbuminuric group were significantly higher than the BNP level of patients in the microalbuminuric group, which indicated statistical significance (P 〈 O. 05 ). Conclu- sions: BNP levels of Type 2 diabetic nephropathy patients were quite high. Type 2 diabetics with normal albuminuria, micro albuminuria and macro albuminuria showed significant differences in their BNP levels.
出处 《贵阳医学院学报》 CAS 2016年第1期67-69,80,共4页 Journal of Guiyang Medical College
关键词 利钠肽 糖尿病 非胰岛素依赖型 蛋白尿 natriuretic peptide, brain diabetes mellitus, non-insulin-dependent proteinuria
  • 相关文献

参考文献11

  • 1Ueda S,Nishio K,Akai Y,et al.Prognostic value of increased plasma levels of brain natriuretic peptide in patients with septic shock[J].Shock,2006(2):134-139.
  • 2Wang TJ,Larson MG,Keyes MJ,et al.Association of plasma natriuretic peptide Levels with metabolic risk factors in ambulatory individuals[J].Circulation,2007(11):1345-1353.
  • 3Cowie MR.Clinical applications of B-type natriuretic peptide(BNP)testing[J].Eur Heart J,2003(24):1710-1718.
  • 4Nielsen LS.N-terminal pro-brain natriuretic peptide for discriminating between cardiac and non-cardiac dyspnea[J].Eur Heart J Fail,2004(3):51.
  • 5Leosdottir M,Willenheimer R,Hall C,et al.Age and gender differences in the association between Nt-pro BNP and glucometabo-lic disturbances[J].Scandinavian Cardiovascular Journal,2011(5):294-300.
  • 6Isotani H,Kameoka K,Sasaki I,et al.Plasma brain natriuretic peptide levels in normotensive type 2 diabetic patients without cardiac disease[J].Diabetes Care,2000(6):859-860.
  • 7Peng Q,Hu W,Hai SU,et al.Levels of B-type natriuretic peptide in chronic heart failure patients with and without diabetes mellitus[J].Experimental and therapeutic medicine,2013(1):229.
  • 8Welsh GI,Coward RJ.Podocytes,glucose and insulin[J].Curr Opin Nephrol Hypertens,2010(4):379-384.
  • 9Gall MA,Borch-Johnsen K,Hougaard P,et al.Albuminuria and poor glycemic control predict mortality in NIDDM[J].Diabetes,1995(44):1303-1309.
  • 10Gerstein HC,Mann JF,Yi Q,et al.Albuminuria and risk of cardiovascular events,death,and heart failure in diabetic and nondiabetic individuals[J].JAMA,2001(25):421-426.

同被引文献30

引证文献5

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部